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Antibody responses of the immunoglobulin E  (IgE) class are regulated by a  finely 
tuned  network of cellular and  molecular interactions.  The differentiation  of IgE B 
lymphocytes is controlled by antigen-specific and non-antigen-specific T  helper and 
suppressor  cells  and  their  molecular  products  (1-3).  The  antigen-specific  cellular 
interaction can be carried out by thymus-derived (T) cells which recognize immuno- 
genic carriers  through  the hapten-carrier bridges  (4-6).  A  common idiotypic deter- 
minant  has  been  shown  in  antibody  responses  of the  IgE  and  IgG classes  to  the 
synthetic polypeptide antigen L-glutamic acid-t-alanine-L-tyrosine (7).  TEPC-15  (T- 
15) x idiotypic  determinant  has  been  shown  in  serum  IgE  antibodies  specific  for 
phosphorylcholine  (PC)  (8),  and  surface  tg  of  IgE  precursor  cells  (9).  Idiotypic 
determinants present on IgE molecules are functionally important in regulating the 
production  of IgE molecules, since suppression of the IgE antibody response to PC 
can be achieved by isologous anti-T-15 antiserum  (8).  Recently, the existence of the 
T-15  idiotypic  determinant  has  also  been  demonstrated  on  PC-mycobacterium- 
primed  T  cells,  and  PC-specific  T  cell  hybridoma  (10).  Likewise,  IgE  antibody 
responses  to  benzyl-penicilloyl  coupled  to  carrier  proteins  can  be  suppressed  by 
isologous antiidiotypic antibodies raised against carrier-specific antibodies (11), which 
suggests that regulatory T  cells may be dampened through the idiotypic determinants 
of antigen-specific receptors on T  cells. 
More apparent  than  with  other classes of Ig, IgE antibody responses  have been 
found to be stringently controlled  by non-antigen-specific IgE class-restricted regu- 
latory cells  (1,  12-17)  and  their molecular products  (1,  2,  15-22).  Much  effort has 
been directed to elucidate the molecular basis of this class-restricted regulation in the 
IgE antibody  system.  It  has  been  clearly  established  by studies  conducted  in  the 
laboratories of Ishizaka and Kishimoto (10,  15-17, 23) that certain cells and molecules 
participating  in  the  regulation  of IgE antibody response display  IgE heavy chain- 
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specific binding activities. Studies by Yodoi et al.  (16, 23) and Hirashima et al.  (17) 
demonstrated that IgE potentiating and suppressive factors differ in the content of 
carbohydrate moieties, and that both factors bind to affinity columns prepared with 
IgE on Sepharose 4B. Likewise, Sugimura et al. (10) and Suemara et al. (15) showed 
that  IgE binding factors, displaying IgE class-restricted regulatory activity, can be 
obtained  from  2,4-dinitrophenyl  (DNP)-mycobacterium-primed T  cells  and  from 
hybridomas prepared by fusion of DNP- or PC-mycobacterium-sensitized spleen cells 
with the T  lymphoma cell line, BW5147. 
Work conducted in this laboratory has concentrated on delineating the difference 
underlying the IgE response phenotype of low and high responder mice. Two IgE- 
restricted regulatory factors have been identified, one of which is suppressive, termed 
suppressive  factor  of allergy  (SFA),  and  the  other,  which  is  enhancing,  termed 
enhancing  factor of allergy  (EFA)  (21,  22).  The  amount  of SFA  can  be  greatly 
exaggerated in serum and ascites fluids induced by repeated inoculation of complete 
Freund's  adjuvant  (21).  Recently, Chen  et  al.  (24)  showed  that  IgE-binding  cells 
(FcR¢÷ cells) can be induced de novo in murine lymphocytes, and that SFA can down- 
regulate the induction of IgE binding cells.  We speculated that  SFA may interact 
with the IgE-binding precursor cells at an early stage, functioning as anti-receptor 
molecules to prevent the appearance of IgE-binding cells. 
Thus,  it  appears  that  regulation  of the  IgE  antibody  system  is  executed by  a 
combination of antigen-specific regulation via a  hapten-carrier bridge and idiotypic 
determinants  and  an  IgE  isotype-specific regulatory  network  through  the  linked 
recognition of E heavy chain of IgE molecules by IgE-binding cells, that,  in  turn, 
communicate with regulatory cells or factors that react with cell receptors for IgE. If 
such an isotype-specific regulatory network exists, we reasoned that the IgE antibody 
system might be susceptible to manipulation with molecules that interact specifically 
with the relevant cellular components in immature animals. We thus administered 
soluble  IgE  or  cell-bound  IgE,  i.e.,  IgE  covalently coupled  to  cell  membranes  of 
syngeneic spleen cells, to both high  and  low IgE responder mice beginning at  the 
neonatal  period  of life.  In  this  paper  we  report  a  novel  type  of immunological 
tolerance induced selectively and polyclonally in the class of IgE antibody responses 
by such treatments. 
Materials and Methods 
Animals.  (BALB/c × A/J)F1 (CAF1) and (BALB/c × SJL)F1 mice were obtained from the 
breeding colonies in the animal facility of Scripps Clinic and Research Foundation, La Jolla, 
CA. Parental strains of female BALB/c and male A/J and SJL mice were purchased from The 
Jackson Laboratory, Bar Harbor, ME. Adult male Lewis rats were bought from Holtzman Co., 
Madison, WI. 
Reagents 
PROTEINS AND CHEMICALS.  The following materials were used: 2,4,6-trinitrobenzene  sulfonic 
acid  (TNBS)  (ICN  Nutritional Biochemicals,  Cleveland,  OH); keyhole limpet hemocyanin 
(KLH) (Pacific Bio-Marine Laboratories, Venice, CA); bovine serum albumin (BSA), ovalbu- 
min (OVA), dithiothreitol (DTT), and glutaraldehyde (Sigma Chemical Co., St. Louis, MO); 
cyanogen bromide activated Sepharose-4B and N-succinimidyl 3-(2-pyridyldithio)  propionate 
(SPDP) (Pharmacia Fine Chemicals, Uppsala, Sweden). DNPm-BSA was prepared as previously 
described (25). 
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classes specific for the DNP hapten  were obtained  from hybridomas  constructed  and charac- 
terized as reported in detail previously (26);  the IgE, IgGi, and IgGzb DNP-specific antibodies 
were isolated by affinity chromatography  on DNP-BSA-coupled Sepharose  4B.  Rabbit  anti- 
mouse IgA was purchased from Bionetics Laboratory Products, Litton Bionetics, Inc., Kensing- 
ton,  MD;  other  conventional  antibodies  were  prepared  in  our  laboratory  and  purified  by 
affinity chromatography on specific immunoadsorbent  columns. These included: routine anti- 
KLH specific antibodies,  rabbit  anti-mouse  IgG (RAMG),  goat anti-rabbit  immunoglobulin 
(GARG), rabbit anti-KLH, and rabbit anti-BSA. 
Covalent Conjugation of Proteins to Splenocytes or Sheep Erythrocytes (SRBC) 
CHEMICAL  CONJUGATION  THROUGH  HETEROBIFUNCTIONAL  REAGENT,  N-SUCCINIMIDYL  3-(2- 
PYmDVLDITmO) PROPIONATE (SPDP) (27, 28).  20 mM SPDP was freshly prepared  by dissolving 
6.24  mg of SPDP  in  1.0  ml of absolute ethanol.  50/A of 20 mM SPDP  was added  to DNP- 
specific monoclonal IgE, IgGi, or IgGeb at  1 mg/ml phosphate-buffered  saline (PBS), pH 7.5. 
The tube was sealed with paraffin  paper and left for 30 rain with occasional stirring at room 
temperature.  The excess SPDP reagent was removed by dialysis. The resulting 3-(2-pyridyldi- 
thio)  propionyl  protein  (PDP  protein)  was  recovered  and  the  degree  of conjugation  was 
estimated by the amount of pyridine-2-thione released upon reduction by DTT. Approximately 
60 PDP groups were conjugated to 106 daltons of protein molecules. 0.5 ml of 0.01  M  DTT was 
added  to  10 ml of 2% spleen-cell suspension, or 0.5 m] of 1 M  DTT was added  to 10 ml of 2% 
SRBC suspension. The reduction reaction proceeded at room temperature for 1 h. DTT-treated 
cells were washed thoroughly and then resuspended in PBS, after which PDP-proteins at  1 rag/ 
ml were added  in equal volume at room temperature  for  1 h.  Protein-coupled  splenocytes or 
SRBC were washed twice in PBS and resuspended  at appropriate  concentrations in saline for 
injection. 
CONJUGATION  OF IGE MONOCLONAL ANTIBODIES  TO LYMPHOCYTES BY CHEMICAL-REACTIVE  HAPTEN~ 
TNnS.  10 mM of TNBS was prepared by dissolving 35 mg of TNBS in  10 ml of PBS. Spleen- 
cell  suspensions  were  prepared  at  2  ×  108  cells/ml  in  PBS.  1.0  ml  of  10  mM  TNBS  was 
added  slowly to  1 X  108  splenocytes in  0.5  ml  PBS  and  the reaction  proceeded with  gentle 
stirring at room temperature for 10 rain. TNBS-conjugated spleen cells were washed extensively 
and  finally  resuspended  at  1%  (vol/vol)  in  PBS  to  which  DNP-specific  monoclonal  IgE 
antibodies were added at a final concentration of 40 #g/ml. After incubation at 37 ° in a water 
bath at room temperature for 30 min, the antibody-coated splenocytes at  1% (vol/vol) in PBS 
were mixed with an equal volume of 4% glutaraldehyde at room temperature for 30 min. Cells 
were washed three times in PBS and then resuspended  at appropriate concentrations in saline 
for injection. 
Hemagglutination Assay.  Serial twofold dilutions of antisera (25 #1) were made in 1% newborn 
calf serum (NCS)-PBS in a round-bottomed 96-well plate to which indicator cells at 0.5% (voI/ 
vol)  in  1% NCS-PBS were added  in  25 #l.  The plate was covered with paraffin  and  the end 
point of agglutination was determined after the plate was incubated  at room temperature  for 
2h. 
Assessment of lmmune Responses 
MEASUREMENT OF ANTI-KLH ICE ANT1BOmES.  The  level of KLH-specific IgE antibodies  in 
pools  of sera  from  each  group  was  determined  by  passive  cutaneous  anaphylaxis  reactions 
(PCA)  using  shaven  male  Hohzman  rats  (4).  Serial  twofold dilutions  of sera  were  made  in 
saline containing 1% normal rat serum.  100 #1 of each dilution was injected into the dorsal skin 
area of the test rats. The PCA reactions were elicited 4 h or overnight after skin sensitization by 
intravenous  injection  of  1.0  mg of KLH  in  2.0  ml  of 0.05%  Evan  blue  dye.  The  titer  was 
recorded as the reciprocal of the highest dilution of serum evoking threshold PCA reactivity. 
RADIOIMMUNOASSAY  (RIA)  FOR  ANTI-KLH IGG  RESPONSES.  A  solid-phase  RIA  system  using 
RAMG and GARG antibodies was used to measure the amount of KLH-specific IgG antibodies 
in sera of hyperimmune mice. 96-well Flex-vinyl U-bottomed microtiter plates  (Cooke Labo- 
ratory Products Div., Dynatech Laboratories, Inc., Alexandria, VA) were coated with  100 #g/ 
ml solution of KLH at room temperature for 2 h. The plates were subsequently saturated with 
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were added  100/~l of either affinity-purified KLH-specific antibodies ranging from 0.05 ng to 
100 ng/ml of 1% NCS-PBS (to obtain a standard curve), or the test serum samples which were 
diluted  103- to  107-fold  in  1% NCS-PBS. After 2 h  incubation at room temperature,  the plates 
were washed and  to each well was added  100/d  of affinity-purified RAMG at  1 ~g/ml. The 
plates were incubated at room temperature for 2 h. Finally, 50,000 cpm of lzSI-labeled affinity- 
purified GARG in 100/d was added. The plates were incubated overnight at 4°C and the wells 
were washed, dried, cut off with a hot wire, and counted in an automatic gamma counter. The 
concentration of KLH-specific IgG antibody in the appropriately diluted sample was interpo- 
lated from the linear portion of the standard  curve. Statistical analysis of geometric means and 
standard errors of the means were obtained from at least four individual values in each group. 
The P  values of Student's t test between treated and control groups were determined. All the 
computation and statistical analyses were performed by programs stored in a TRS-80 model II 
(Radio Shack, Div. of Tandy Corp., Ft Worth, TX) microcomputer. 
Results 
Coupling of Monoclonal Antibodies and Proteins to Splenocytes.  A general method for the 
coupling of proteins to splenocytes through disulfide-bond formation is summarized 
in Fig.  1. The procedure involves three steps. First, the PDP residues are introduced 
into the protein by the reaction of a portion of the amino groups of the protein with 
a heterobifunctional reagent, SPDP. The reagent contains one N-hydroxy succinimide 
ester moiety and one 2-pyridyl disulfide moiety. The hydroxy succinimide ester reacts 
with primary amino groups to give stable bonds, resulting in PDP protein. Thedegree 
of substitution can be controlled by using different amounts of reagent and lengths of 
reaction time to preserve the integrity of the protein molecules. Second, the addition 
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of reducing reagent, DTT, converts the disulfide bonds of membrane proteins into 
thio groups. Thus, in the third reaction, the PDP protein conjugates are covalently 
coupled to DTT-treated cells. 
Using  this  approach,  we  have  been  able  to  couple  monoclonal  antibodies  of 
different classes  and  varieties of proteins to  SRBC  and splenocytes, and assess  the 
efficiency of coupling by  agglutination reaction with  the  respective antiserum. As 
shown  in Table I,  six  proteins thus  far  tested,  BSA,  KLH,  monoclonal IgE,  IgG1, 
IgG2b,  and IgA can be coupled to  1 M  DTT-treated SRBC. All these indicator cells 
are agglutinated by appropriate antisera. In exploratory experiments, we determined 
that 0.01  M  DTT can reduce enough disulfide bonds on splenocyte membranes such 
that  PDP-proteins were coupled with equal efficiency. Thus, as shown in Table I, 
0.01  M  DTT-treated splenocytes coupled with BSA and IgE via the SPDP method 
are  agglutinated effectively and  specifically by  affinity-pure rabbit  anti-BSA and 
rabbit anti-mouse IgE antisera, respectively. These indicator cells, as shown here, can 
be used to detect  from 0.01  to 0.15/Lg of specific antibody molecules in the aggluti- 
nation assay. 
Radiolabeling tracer studies using 125I-labeled PDP-IgE demonstrated that  there 
are ~ 10 ng of IgE molecules on 25-50 ×  106 cells, whereas chemical conjugation of 
splenocytes with TNBS, using 125I-labeled IgE as  the radioactive tracer, resulted in 
the attachment of ~ 100 ng of DNP-specific IgE molecules on 25-50 ×  106 cells (data 
not shown). 
General Experimental  Design.  Because inbred mice vary in IgE-response phenotype 
according to strain (29), we first confirmed in pilot studies that the mice used in these 
TABLE  I 
Immunological Specificities of Proteins:Cell ConflLgates Prepared by the SPDP 
Method 
PDP-protein cou-  Antibodv indicators  HA titer 
pied ceils 
IgG1-SRBC  Rabbit anti-mouse IgG  8 
IgG2b-SRBC  Rabbit anti-mouse IgG  9 
IgA-SRBC  Rabbit anti-mouse IgA  6 
KLH-SRBC  Rabbit anti-KLH  11 
IgE-SRBC  Affinity-pure  rabbit anti-BSA  0 
IgE-splenocytes  at 0.1 mg/ml  0 
BSA-SRBC  9 
BSA-splenocytes  8 
IgE-SRBC  Affinity-pure  rabbit anti-mouse  5 
lgE-splenocytes  lgE at 0.1 mg/ml  4 
BSA-SRBC  0 
BSA-splenocytes  0 
I0 m[ of 2% SRBC or single-cell  suspension  of routine spleen  cells  was prepared, 
to which 0.5 ml of 1.0 M or 0.01 M DTT was added. The reaction proceeded 
at room temperature for 1 h, and ceils were washed and resuspended at 25% 
in PBS, to which equal volumes  of PDP-protein conjugates at  1 mg/ml were 
added. After I h conjugation reaction, these cells were washed; a  1% cell 
suspension was then made in  1% newborn calf serum-PBS and was reacted 
with rabbit antisera and affinity-pure  antibody reagents in a hemagglutination 
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studies  displayed  dominant  inheritance  of high  IgE-responder phenotype  in  both 
(BALB/c ×  SJL)F1 and (BALB/c X A/J)FI as previously shown by Watanabe et al. 
(13) and Tung et al. (21). 
In  the  experiments that  follow, F1 hybrid  mice were treated with  the  materials 
being tested at least three times during the first 3 wk of life, with the initial treatment 
always  administered  within  the  first  12-15  h  after  birth  (day  0).  In  two  of the 
experiments presented, two or three additional treatments were given after the 3rd wk 
of life (Figs.  5 and 2, respectively). In all experiments, the materials tested included 
control  samples  consisting  of saline  and/or  25-50  X  106  unconjugated  syngeneic 
spleen cells, and  experimental samples consisting of 250/tg  of soluble  monoclonal 
DNP-specific IgE and/or 25-50  ×  10  °  antibody-conjugated syngeneic spleen cells. 
Cell numbers are expressed as a  range of 25-50 X  106 because the actual  number 
injected at a given treatment point varied within this range depending on the extent 
of cell recovery of the treated populations after chemical conjugation procedures. In 
any case, the numbers were kept equivalent among the various groups injected at a 
given point  in  time.  In  all  experiments, the  volumes in  which  test  materials  were 
injected were 50/xl per recipient mouse in each of the first two injections, 100/xl in the 
third injection, and 500/xl in all injections thereafter (all administered intraperitone- 
ally). With the exception of one experiment (Table II), immunizations of experimental 
and control mice were initiated when they reached 2.5 mo of age.  Finally, all mice 
surviving through the neonatal period manifested good general health states irrespec- 
tive of the nature of the test material to which they had been exposed. 
Induction of IgE Class-restricted Tolerance by Neonatal Exposure of (BALB/c  X  SJL)F1 
Mice to Soluble IgE or IgE-conjugated Syngeneic Spleen Cells.  Groups of four (BALB/c × 
SJL)F1 mice were treated on six occasions (days 0, 7,  17, 24, 34, and 59) after birth 
with saline, soluble IgE, or syngeneic spleen cells, either unconjugated or conjugated 
with IgE. The IgE-conjugated cells were prepared by the direct SPDP or the indirect 
TNBS methods. At 2.5 mo of age, all mice were immunized with  10/~g of KLH in 
alum,  followed 2  wk  later  by a  booster  injection of 1 ~g  of KLH  in  alum.  10  d 
thereafter, all mice were bled and their sera analyzed for KLH-specific IgE and IgG 
antibody levels. 
The results of this experiment are graphically summarized in Fig. 2 and make three 
very obvious points. First, administration of soluble IgE, according to this treatment 
regimen,  abolishes  the  capacity  of such  treated  mice  to  develop  subsequent  IgE 
responses. Second, mice treated with cell-bound IgE were similarly refractory to the 
development of IgE antibody responses, irrespective of the method of coupling used 
to prepare the IgE-conjugated syngeneic spleen cells.  Furthermore, it is noteworthy 
that the depth of unresponsiveness in the IgE class was comparable to cell-bound IgE 
or soluble IgE, despite the fact that the absolute amount of IgE administered via cells 
was 2,500-fold (or more) less than the amount of soluble IgE administered.  (It should 
be  noted,  however,  that  practical  considerations  prevented  us  from  performing a 
thorough titration to determine the minimum amount of soluble IgE needed to obtain 
the  unresponsive state.)  Finally, the  inability of treated  mice to develop antibody 
responses was absolutely restricted to the IgE class, since, as shown in Fig. 2, IgG anti- 
KLH antibody responses of all groups were comparable in magnitude. 
To rule out the possibility that the effects observed by treatment with DNP-specific 
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INDUCTION  OF IgE CLASS-RESTRICTED  TOLERANCE  BY NEDNATAL 
EXPOSURE OF (BALB/c xSJL)F~ MICE  TO SOLUBLE 
IgE OR IgE-CONJUGATED  SYNGENEIC  SPLEEN CELLS 
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FIC.  2.  Induction of IgE class-restricted  tolerance by neonatal  exposure  of (BALB/c X SJL)F1 
mice to soluble IgE or IgE-conjugated syngeneic spleen cells. (BALB/c X SJL)FI hybrid mice were 
injected intraperitoneally with 250 /~g of soluble  IgE, [gE bound  to 25-50  ×  106 splenoeytes,  or 
control material in 50 #1 saline on days 0 and 7 after birth and in 100 btl saline on day 17. Mice in 
each group were later given the same material in 500 #1 saline intraperitoneally on days 24, 34, and 
59. At ~2.5 mo of age,  the mice were immunized intraperitoneally with  10 #g of KLH in 2 mg 
alum, and  14 d later they were boosted with 1 #g of KLH in 2 mg alum. Sera were collected 10 d 
later.  The IgE anti-KLH antibody responses were measured by PCA reactions  and the IgG anti- 
KLH antibody responses were measured by RIA. Concentration oflgG anti-KLH antibody response 
is expressed  as geometric means ±  SE of the means of at least  four individual values from each 
group. 
were performed  in  which  mice treated  in  similar ways,  but  on  only three  occasions, 
were doubly immunized, with both KLH  and OVA. The results of these experiments, 
summarized  in Table  II, clearly demonstrated  that  such  treatments  with  IgE-conju- 
gated  syngeneic  spleen  cells  or  soluble  IgE  induced  IgE  class-restricted  tolerance 
irrespective of whether  KLH  or OVA  was  used  for antigenic  challenge.  Significant 
reduction  of total  serum  IgE was  also detected  in  mice treated  with  IgE-conjugated 
spleen cells (data  not shown),  which corroborated  the notion of polyclonal induction 
of IgE class-restricted  tolerance in the system  described here. 
Persistence of IgE  Class-restricted Tolerance and  Failure  to  Induce Such Tolerance with 
Syngeneic  Spleen  Cells  Coupled with  Monoclonal Antibodies  of  Other hnmunoglobulin 
Classes.  (BALB/c  ×  SJL)F1 hybrid  mice were treated  three  times within  the first  3 
wk after birth  (days  0,  7,  and  20)  with  saline,  soluble IgE, or syngeneic spleen cells. 
The  syngeneic spleen  cells were either unconjugated  or conjugated  (by  SPDP)  with 
IgE or a  mixture of DNP-specific monoclonal antibodies of the IgG1 and IgG2b classes. 
Immunization  with  1  #g  of  KLH  in  alum  was  initiated  at  2.5  mo  of  age  and 
administered  on three occasions  (days 0,  10, and  24).  The mice were bled on multiple SWEY-SHEN CHEN  AND DAVID H.  KATZ 
TABLE II 
Treatment of (BALB/c  X  SJL)F1 Mice with Monoclonal IgE Results in Induction of 
Polyclonal IgE Class-restricted Tolerance to Either KLH or 0 VA Challenge 
779 
Experi-  Groups  Treatment 
merit 
IgE antibody responses 
(PCA titer) 
Anti-KLH  Anti-OVA 
response  response 
I  1  II 
Unconjugated spleen cells  1,280  1,280 
lgE-conjugated spleen celIs-(SPDP)  <I0  160 
I  Saline  1,280  320 
II  Soluble IgE  <I0  <10 
III  Unconjugated spleen cells  1,280  1,280 
IV  IgE-conjugated spleen celIs-(SPDP)  40  <10 
Experiment 1: (BALB/c X SJL)F1 mice were treated with unconjugated spleen cells or IgE 
coupled spleen cells on days 0, 10, and 22 after birth. Immunization started when they were 
1.5 mo old. Mice received three injections  of 1 #g KLH in 2 mg alum and one injection of 1 
pg OVA in 2 mg alum, and were boosted with a mixture of 1 #g each of KLH and OVA in 
2 mg alum. The sera from four mice per group were collected 10 d after the last booster 
injection, and assessed for IgE anti-KLH and anti-OVA responses by PCA. Experiment 2: 
(BALB/c × SJL)F1 mice  were treated with the materials indicated on days 0, 7, and 20 after 
birth. Immunization started when they were 2.5 mo old. Mice received three injections of 1 
~g KLH in 2 mg alum and one injection of 1 #g OVA in 2 mg alum intraperitoneally, and 
were boosted with a mixture of I ~g each of KLH and OVA in 2 mg alum. The sera were 
collected and assessed for IgE antibody responses as above. 
occasions throughout and after the immunization period for analysis of IgE and IgG 
anti-KLH antibody responses. 
The results of this study, depicted in Fig. 3,  illustrate two major points. First, as 
before, administration of either soluble IgE or cell-bound IgE resulted in profound 
unresponsiveness of treated  mice with regard  to  their abilities to develop antibody 
responses in the IgE class. No diminution in responses of such mice in the IgG class 
were observed. This IgE class-restricted unresponsive state resisted repeated antigenic 
challenges over  a  relatively prolonged period  of time:  Mice  failed  to  display IgE 
responses even after three KLH  immunizations and as long as  30 d  after the third 
KLH challenge. 
Second,  Fig.  3  illustrates  quite  clearly  that  the  induction of  isotype-restricted 
unresponsiveness is  (a)  highly specific,  since syngeneic spleen cells coupled with  a 
mixture of IgG1 and IgG2b monoclonal antibodies fail to exert any detectable effect 
on IgE antibody responsiveness; and (b) may be unique to the IgE antibody system, 
since mice treated  with cell-bound IgGa plus IgG2b antibodies did not  display any 
appreciable difference in their capacity to mount anti-KLH antibody responses of the 
IgG class. Because responses in these two subclasses represent a significant component 
of the total IgG response to immunization in this manner, one might have expected 
to see some diminution in total IgG anti-KLH antibody levels if treatment with these 
cell-bound antibodies had  had  any appreciable effect  on  the  antibody-producing 
mechanisms of treated mice. 
The  form  of IgE administered was  important in  determining the  length of IgE 
class-restricted tolerance. In the experiment that followed, (BALB/c ×  SJL)F1  mice 
were treated three times  (days 0,  7,  and 20)  with saline, soluble IgE, unconjugated 780  POLYCLONAL IgE CLASS-RESTRICTED TOLERANCE 
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Fro- 3.  IgE class-restricted  tolerance of (BALB/c × SJL)F1 mice treated with soluble or ceil-bound 
IgE resists repeated antigenic challenges for long periods of time. (BALB/c X SJL)F1 hybrid mice 
were injected intraperitoneally with 250/.tg of IgE, IgE bound to 25-50 ×  104 splenocytes,  or control 
material in 50 p,l saline on days 0 and 7 after birth and in 100/~l saline on day 20. At 2.5 mo of age, 
they were immunized intraperitoneally with 1/tg of KLH in 2 mg alum and boosted on days 10 and 
24  thereafter. Sera of these mice were collected on days 10,  24,  31,  41,  and  54  after initial 
immunization and analyzed for IgE (panel A) and IgG (panel B) anti-KLH antibody responses. 
spleen cells, or IgE coupled to syngeneic spleen cells via SPDP or TNBS. Mice were 
primed with 1/~g of KLH in 2 mg alum when they were 2.5 mo old and then boosted 
with same four more times over a  period of 7 mo. Sera were collected  10-16 d  after 
each antigenic challenge. As shown in Fig. 4, long-term IgE class-restricted tolerance 
was induced in mice treated with both soluble IgE and IgE-coupled syngeneic spleen 
cells.  However,  IgE-coupled syngeneic cells served  as  better tolerogen than soluble 
IgE, since tolerance persisted for 9 mo after five sequential KLH challenges in mice 
treated with IgE-coupled syngeneic cells by SPDP or TNBS, whereas tolerance was 
lost in mice treated with soluble IgE. IgG anti-KLH responses among all groups of 
mice were not significantly different (data not shown). 
Induction of IgE Class-restricted Tolerance by Neonatal Exposure of (BALB/c  X  A/J)F1, 
(CAFs) Mice to Soluble IgE but Not to IgE Coupled to Syngeneic Spleen Cells.  BALB/c and 
A/J strains of mice both display the high IgE-responder phenotype. Their F1 hybrid, SWEY-SHEN  CHEN  AND  DAVID  H.  KATZ 
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saline, soluble IgE, unconjugated spleen cells, or IgE coupled to syngeneic spleen cells via SPDP or 
TNBS. At 2.5 mo of age, the mice were primed with 1 #g of KLH in 2 mg alum, and four sequential 
boosts of the same were given over a  period  of 7  too.  Sera were collected  10 to  16 d  after each 
antigenic challenge. IgE antibody responses to KLH of four mice in each group are depicted. 
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Fro..5.  Induction of IgE class-restricted  tolerance  by neonatal exposure  of (BALB/c  X A/~)F] 
mice to soluble  IgE or IgE-conjugated  syngeneie  spleen  cells. (BALB/C  X A/~)F] hybrid mice  were 
injected intraperitoneally with 250/~g of soluble IgE, IgE bound to 25-50 X  l06 lymphocytes  or 
control material in 50 #l saline on days 0 and 7 after birth and in 100 #1 saline on day 17. Mice were 
later given the same material in 500 #l saline intraperitoneally on days 34 and 42. The immunization 
protocol  and  IgE and  IgO  anti-KLH  antibody  assays were  performed as those described  in the 
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(BALB/c ×  A/J)Fa, CAFa, is homologous with respect to the genetic determinants for 
IgE responsiveness, and has been demonstrated to be a high IgE-responder mouse as 
well  (30).  We  proceeded  to  determine  whether  class-restricted  tolerance  can  be 
induced as well in CAF1 mice with soluble and/or cell-bound monoelonal IgE. Thus, 
CAF1 mice were given five repeated treatments (days 0, 7, 17, 34, and 42) with saline, 
soluble IgE, unconjugated spleen ceils, or IgE coupled to syngeneic spleen cells via 
SPDP or TNBS. They were immunized with  KLH  in  alum  at  2.5  mo  of age.  As 
shown in Fig. 5, profound IgE class-restricted tolerance was induced in the group of 
mice that received repeated injections of high doses of soluble IgE as compared with 
the control group given repeated injections of saline (groups I and II). But in distinct 
contrast with the IgE class-restricted tolerance observed in (BALB/e ×  SJL)F1 mice, 
this isotype-restricted tolerance could not be induced by monoclonal IgE coupled to 
syngeneic CAF1 spleen cells irrespective of the conjugation method used. These results 
indicated  the  importance of the products specified by genetic determinants of IgE 
low-responder mice in association with the IgE molecules covalently coupled to the 
membrane of spleen cells and, furthermore, suggested that IgE class-restricted toler- 
ance may be induced by two different mechanisms: (a) exposure to high concentrations 
of IgE molecules directly, and (b) exposure to low concentration of IgE in association 
with relevant products on cell surfaces of lymphoid cells. 
Discussion 
The experiments presented here demonstrate the following four points (a) polyclonal 
induction  of tolerance  of the  IgE  antibody  system  can  be  induced  by  neonatal 
administration of monoclonal IgE to mice;  (b)  (high X  low) IgE-responder F1 mice 
can be rendered tolerant by exposure to two forms of tolerogens, i.e., soluble IgE and 
IgE coupled to syngeneic cells, whereas (high ×  high) IgE-responder mice are rendered 
tolerant only by exposure to soluble IgE; (c) the tolerance induced is restricted to the 
IgE class since it cannot be induced by monoclonal antibodies of other Ig classes, and 
the  tolerance, once  induced,  is  manifested  only  in  the  IgE,  and  not  in  the  IgG, 
antibody  class  response;  and  (d)  the  IgE  class-restricted  tolerance  resists  repeated 
antigenic challenges, and IgE coupled to syngeneic cells is more effective than soluble 
IgE in inducing prolonged IgE class-restricted tolerance. 
Previously, other investigators (31-34) have demonstrated the capacity to modulate 
immune responses in an idiotype-, allotype-, and possibly isotype-specific manner by 
perturbing  regulatory helper and/or suppressor T  ceils,  and  perhaps  B  cells,  after 
treatment of experimental animals  with various anti-immunoglobulin  antibody re- 
agents. The system presented in this report differs from such previous observations, 
however, in that an isotype-specific lesion of the IgE class was induced by perinatal 
exposure of experimental animals to the specific immunoglobulin in question, namely 
IgE. To our knowledge, this is the first demonstration of the induction of such  an 
isotypic lesion which results in substantial  diminution in the ability of such treated 
animals to produce IgE antibodies for prolonged periods of time after treatments of 
this type. 
The mechanism  of this  phenomenon has not  yet been  delineated.  However, the 
observations made thus far in this system do permit several educated interpretations 
and speculations. First, it is unlikely that some form of idiotype-specific suppression 
mechanism  (i.e.,  antibody or cells)  was  induced by administration of DNP-specifie SWEY-SHEN CHEN AND DAVID H. KATZ  783 
monoclonal IgE  molecules that  would,  in  turn,  cross-inhibit  immune  responses  to 
complex protein antigens such as KLH and OVA.  By the same reasoning, carrier- 
specific suppression mechanisms are unlikely to be involved since KLH and OVA are 
non-cross-reactive carrier antigens. Second, it is not probable that allotypic determi- 
nants on the administered IgE molecules induced allotype-specific antigen-nonspecific 
suppression mechanisms that would regulate both anti-KLH and anti-OVA responses, 
because one would expect such suppressive mechanisms to be similarly exerted on 
antibody  responses  of the  IgG  class.  Third,  it  is  unlikely  that  the  administered 
monoclonal IgE antibodies specific for the DNP hapten cross-reacted with membrane 
immunoglobulins of any other isotype or other cell-surface components against which 
responses might be manifested as IgE class-restricted tolerance. Fourth, the possibility 
that the simple introduction of syngeneic cells that have been modified by chemical 
alteration of cell-surface proteins via the heterobifunctional reagent, SPDP, could, in 
turn, selectively modulate the IgE antibody system was ruled out by the experiment 
presented in Fig. 3 in which cells coupled with IgG molecules by the same chemical 
procedure  failed  to  exert  any  detectable  effect on  the  subsequent  IgE  antibody 
responses. 
The  fact  that  there  were  obvious  differences  between  the  IgE  class-restricted 
tolerance induced by soluble IgE on the one hand, and cell-bound IgE on the other, 
may provide significant clues as to the nature and type(s) of mechanism(s) underlying 
this phenomenon. First, the absolute quantity of monoclonal IgE administered in the 
form of soluble IgE vs. IgE-conjugated syngeneic cells differed at least 2,500-fold; yet 
IgE-conjugated  spleen  cells  appeared  to  be  more  effective in  inducing  IgE  class- 
restricted tolerance for considerably longer periods of time (Fig. 4). We speculate that 
IgE-conjugated spleen cells, processed in vivo, may be more stable and thus persistent 
in tissues, as compared with soluble IgE. 
Second, and more striking, was the finding that although soluble IgE was effective 
in inducing tolerance in both (BALB/c X SJL)F1 and (BALB/c ×  A/J)F1 mice, IgE- 
conjugated syngeneic spleen cells, at the doses used, were effective in inducing such 
tolerance only in  the  (BALB/c  ×  SJL)Fa hybrids  (Figs.  2  and  5).  This  difference 
implies, but does not prove, that  products contributed to by SJL genetic elements, 
probably the cell-surface determinants, are important in the induction of this tolerance 
phenomenon when IgE-conjugated splenocytes are used. This could mean that such 
determinants are involved either in presentation of the relevant IgE determinant(s) 
important in this mechanism or in the recognition of the IgE-conjugated spleen cells 
used. Syngeneic lymphocytes modified with hapten or particular idiotypes have been 
demonstrated  to  exert  a  potent  negative  regulatory effect on  hapten-  or idiotype- 
specific responses in other experimental systems  (35-37).  Determinants encoded by 
the  major  histocompatibility  complex  (MHC)  played  critical  roles  in  presenting 
haptens to trigger precursor suppressor T cells, and the suppressor T cells thus induced 
were shown to be restricted to the hapten-MHC complex (35).  Although the MHC 
appeared to play no role in presenting idiotype to precursor suppressor T  cells (36- 
37),  nevertheless,  idiotype-specific T  suppressor  cells  must  be  Igh  congenic to  the 
idiotypic molecules' present syngeneic lymphocytes. In the system presented herein, 
the  importance  of MHC  gene  products,  Igh  gene  products,  or  other  cell-surface 
determinants  on  both  presenting  and  responder  cells  must  be  assessed  in  future 
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successful induction of tolerance by IgE-conjugated cells must necessarily derive from, 
or be related to, the low IgE-responder haplotype must be further delineated. Finally, 
in this regard, the ability to induce tolerance with both soluble and cell-bound IgE in 
(high  ×  low)F1 animals,  but  only with  soluble IgE  in  (high  ×  high)F1  mice, may 
imply two distinct mechanisms of tolerance induction and will require further analysis. 
For example, such differences may only imply that when lower doses of IgE are used, 
such as the quantities presented on IgE-conjugated spleen cells, this pathway may 
require the participation of an additional cell-surface determinant provided by genetic 
elements contributed by the low responder. When soluble IgE is used in doses that are 
many orders of magnitude higher, perhaps the requirement for participation of such 
cell-surface determinants is obviated even though the same mechanistic pathway is 
involved in the ultimate manifestation of tolerance. 
Recently,  several  laboratories  have  demonstrated  the  existence  of lymphocytes 
bearing Fc receptors (FcR) specific for IgE (FcRe  + lymphocytes). Indeed, the increas- 
ing  direct  and  indirect evidence implicating  important  regulatory roles  for FcRe  + 
lymphocytes in the physiological functioning of the IgE antibody system prompted us 
to initiate the studies presented herein. We reasoned that if FcRe  + lymphocytes were 
important  regulatory constituents in  the  development of the  IgE antibody system, 
then perhaps perturbation of such cells by neonatal exposure to sufficient quantities 
of IgE might  induce abnormalities  in the system upon challenge during adult  life, 
such as those observed in these studies. 
Pertinent to this reasoning is the fact that FcRC lymphocytes can be induced by 
monoclonal IgE and have been shown to be expressed by both B and T  cells (24, 38). 
The functional role of FcRe  + T  cells and factors released by such cells in regulating 
IgE antibody responses in vitro has been demonstrated quite clearly by Ishizaka and 
his colleagues (16,  17). A comparably isotype-specific regulatory function of FcRa  ÷ T 
|ymphocytes has been demonstrated to exist in the IgA antibody system by Hoover 
and colleagues (39), and regulatory effects of FcRy  ÷ T cells and their secreted products 
have been previously recorded by Fridman et al.  (40). 
The functions of FcR for IgG on B cells have been implicated recently as important 
molecular sites for relaying differentiation signals. Thus Fc fragments of IgG triggered 
mitogenic responses  of B  cells  and  induced  polyclonal  antibodies  synthesis  in  the 
presence of a T cell factor (41). Moreover, monoclonal antibodies against Fc receptors 
for IgG trigger both mitogenic responses and polyclonal antibody synthesis (42). 
In  the  IgE  antibody  system,  the  recent  studies  of our  own  using  mice  (24) 
demonstrated that SFA can down-regulate the induction by monoclonal IgE of FcRC 
lymphocytes. Such  findings,  together with  those cited  above, may be pertinent  to 
those of the present study. Thus, one can envisage the existence of an isotype-specific 
regulatory network that  regulates the size of the IgE antibody response capacity in 
both neonatal and adult  animals.  Such a  network may operate through the linked 
recognition of the E heavy chain by FcRC cells which,  in turn, communicate with 
regulatory  cells  reactive  with  IgE  precursor  cells,  thereby  giving  rise  to  antigen- 
nonspecific, class-restricted regulation of IgE antibody responses.  After exposure to 
either large quantities of soluble IgE or IgE presented appropriately on the surface of 
syngeneic cell membrane, an effective damping mechanism may be generated through 
either enhanced production of IgE class-restricted suppressor cells, or a  decrease of 
the  efficiency of the  development of an  IgE-selective helper mechanism,  with  the SWEY-SHEN CHEN AND DAVID H. KATZ  785 
resulting impairment of the maturation and differentiation of IgE precursor B cells. 
Studies currently underway are designed to define more precisely the mechanism of 
the IgE class-restricted tolerance reported here and the relative roles of FcR~  ÷ T  and/ 
er B lymphocytes. The further elucidation of the intricate cellular network controlling 
IgE antibody production forthcoming from such  analyses will be important  in our 
understanding of the pathogenesis of allergic diseases and, hopefully, will provide us 
with  an  additional  rationale  for  designing  appropriate  therapeutic  regimens  for 
patients with such disorders. Moreover, the understanding of isotype regulation of the 
IgE antibody system should shed light on isotype-specific regulation of other Ig classes 
as well. 
Summary 
Induction  of IgE  class-restricted  tolerance  was  studied  in  high  IgE-responder 
(BALB/c ×  SJL)FI mice, of which the parental BALB/c and SJL mice are high and 
low IgE-responder mice, respectively. 2,4-Dinitrophenyl (DNP)-specific monoclonal 
IgE was administered to (BALB/c ×  SJL)F1 mice neonatally in two forms: soluble 
IgE at 250/~g per injection, or  10-100 ng of IgE coupled to 25-50 ×  106 syngeneic 
splenocytes by binding to the chemically reactive hapten trinitrobenzene sulfonate 
(TNBS) or directly conjugated via a heterobifunctional reagent, N-succinimidyl 3-(2- 
pyridyldithio) propionate (SPDP). Polyclonal induction of IgE class-restricted toler- 
ance was observed in (BALB/c ×  SJL)Fa mice, neonatally treated with soluble IgE or 
IgE-conjugated syngeneic splenocytes. Thus these mice failed to mount IgE antibody 
responses to either keyhole limpet hemocyanin or ovalbumin challenge, assessed by 
the passive cutaneous anaphylaxis reaction. The IgG antibody responses to these same 
antigens,  however,  were  not  affected  by  this  treatment.  The  IgE  class-restricted 
tolerance induced by both forms of IgE persisted up to at least 6 mo with repeated 
antigenic challenges. IgE coupled to syngeneic cells by TNBS or the SPDP method 
induced  prolonged  tolerance up  to  9  mo.  The  induction  of polyclonal IgE  class- 
restricted  tolerance was  achieved  only by  monoclonal  IgE,  whereas  DNP-specific 
monoclonal IgG1 plus IgG2b coupled to syngeneic splenocytes by the SPDP method 
failed to modulate  either IgE or IgG antibody responses.  In contrast,  (BALB/c × 
A/J)F1 mice, of which both parental strains are high IgE responders, developed IgE 
class-restricted tolerance upon repeated neonatal injection of soluble IgE, but not IgE- 
conjugated  syngeneic  splenocytes,  indicating  that  gene  products  of the  low  IgE- 
responder mice contributed to the effective presentation and/or recognition of ~ heavy 
chain of the IgE molecules. Taken collectively, these results demonstrated that non- 
antigen-specific,  isotype-restricted  tolerance  can  be  induced  in  the  IgE  antibody 
system. The differential induction of IgE class-restricted tolerance by different forms 
of tolerogen  in  the  strains  studied  perhaps  distinguishes  two  underlying  cellular 
mechanisms for IgE class-restricted tolerance. 
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